Plate-based diversity subset screening: an efficient paradigm for high throughput screening of a large screening file (Q34655968)

3 August 2017

title

Plate-based diversity subset screening: an efficient paradigm for high throughput screening of a large screening file (English)

1 reference

3 August 2017

Andrew S Bell

1

1 reference

3 August 2017

Joseph Bradley

2

1 reference

3 August 2017

Jeremy R Everett

3

1 reference

3 August 2017

Michelle Knight

4

1 reference

3 August 2017

Jens Loesel

5

1 reference

3 August 2017

John Mathias

6

1 reference

3 August 2017

David McLoughlin

7

1 reference

3 August 2017

James Mills

8

1 reference

3 August 2017

Robert E Sharp

9

1 reference

3 August 2017

Christine Williams

10

1 reference

3 August 2017

Terence P Wood

11

1 reference

3 August 2017

publication date

5 April 2013

1 reference

3 August 2017

1 reference

3 August 2017

volume

17

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

319-335

1 reference

Diagnosing the decline in pharmaceutical R&D efficiency

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

The productivity crisis in pharmaceutical R&D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

21 January 2018

2011 FDA drug approvals

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Lessons from 60 years of pharmaceutical innovation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Origin and evolution of high throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Impact of high-throughput screening in biomedical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Novel trends in high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Shaping a screening file for maximal lead discovery efficiency and effectiveness: elimination of molecular redundancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

The Design, Annotation, and Application of a Kinase-Targeted Library

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Designing compound subsets: comparison of random and rational approaches using statistical simulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

A ‘Rule of Three’ for fragment-based lead discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Enhanced HTS hit selection via a local hit rate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

The application of non-combinatorial chemistry to lead discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

A decade of fragment-based drug design: strategic advances and lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Efficiency of hit generation and structural characterization in fragment-based ligand discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Virtual screening: an endless staircase?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

"Plate cherry picking": a novel semi-sequential screening paradigm for cheaper, faster, information-rich compound selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

The properties of known drugs. 1. Molecular frameworks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

The importance of being profiled: improving drug candidate safety and efficacy using ion channel profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Fluorescence readouts in HTS: no gain without pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Small-molecule inhibition of HIV-1 Vif.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Regulated gene expression systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Experiences in implementing uHTS--cutting edge technology meets the real world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Using extended-connectivity fingerprints with Laplacian-modified Bayesian analysis in high-throughput screening follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Chemical Tools for Indications Discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-013-9438-X

Early evaluation of compound QT prolongation effects: a predictive 384-well fluorescence polarization binding assay for measuring hERG blockade

21 January 2018

1 reference

12 December 2020

Which aspects of HTS are empirically correlated with downstream success?

1 reference

12 December 2020

Future potential and status of selective sodium channel blockers for the treatment of pain.

1 reference

12 December 2020

High-throughput screening of historic collections: observations on file size, biological targets, and file diversity

1 reference

12 December 2020

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

12 December 2020

10.1007/S11030-013-9438-X

Identifiers

DOI

1 reference

3 August 2017

1 reference